|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
R&D Trends: Bipolar Disorders - Developments in schizophrenia dictate trends in diminutive bipolar disorders pipeline
Price: $3,800.00 (€2,975.28) ($4,560.00 (€3,570.34) Including VAT at 20%)
|
| Publication Date: 01-Apr-2011
Please click here for more information or to purchase this report at our partner store
This report reviews the key dynamics in the drug development pipeline for bipolar disorders. It compares current pipeline trends against those of 2006 and explores the future of treatment in bipolar disorders. |
|
|
Epidemiology: Schizophrenia - Marginalized mental health disorder will continue to remain a public health burden
Price: $3,800.00 (€2,975.28) ($4,560.00 (€3,570.34) Including VAT at 20%)
|
| Publication Date: 25-Mar-2011
Please click here for more information or to purchase this report at our partner store
Overview of schizophrenia definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year prevalent case forecast and key patient segmentations across teh seven major markets |
|
|
Case Study: Autism Spectrum Disorders - Public awareness and physician detailing will drive market growth
Price: $1,900.00 (€1,487.64) ($2,280.00 (€1,785.17) Including VAT at 20%)
|
| Publication Date: 15-Apr-2011
Please click here for more information or to purchase this report at our partner store
This report examines the opportunities and threats within the autism spectrum disorders (ASDs) market. The analysis is intended to support company strategy and decision making by providing actionable recommendations in the current treatment pathway. |
|
|
R&D Trends: Autism Spectrum Disorders - Unknown etiology and low industry interest hinders pipeline progression
Price: $3,800.00 (€2,975.28) ($4,560.00 (€3,570.34) Including VAT at 20%)
|
| Publication Date: 05-Apr-2011
Please click here for more information or to purchase this report at our partner store
This report reviews the key trends in the autism spectrum disorders pipeline. The analysis is intended to support R&D decision-making by evaluating the competitive dynamics of the pipeline and hypothesizing future treatments. |
|
|
R&D Trends: Depression - Pipeline characterized by its depth and diversity
Price: $3,800.00 (€2,975.28) ($4,560.00 (€3,570.34) Including VAT at 20%)
|
| Publication Date: 20-Apr-2011
Please click here for more information or to purchase this report at our partner store
Review of key trends in the development of new depression drugs across the seven major markets. Also includes detailed analyses of clinical trial design, target product profile, innovative early-stage projects, and future treatment developments. |
|
|
|
|
Epidemiology: Autism Spectrum Disorders
Price: $5,700.00 (€4,462.92) ($6,840.00 (€5,355.51) Including VAT at 20%)
|
| Publication Date: 28-Feb-2011
Please click here for more information or to purchase this report at our partner store
Overview of autism spectrum disorder definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year prevalent case forecast, and key patient segments across the seven major markets. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Schizophrenia Market Forecast
Price: $15,200.00 (€11,901.13) ($18,240.00 (€14,281.35) Including VAT at 20%)
|
| Publication Date: 01-Oct-2010
Please click here for more information or to purchase this report at our partner store
Analysis of the current and future schizophrenia market. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) for key marketed brands, generics, and pipeline products. |
|
|
Epidemiology: Depression
Price: $5,700.00 (€4,462.92) ($6,840.00 (€5,355.51) Including VAT at 20%)
|
| Publication Date: 12-Dec-2010
Please click here for more information or to purchase this report at our partner store
Overview of depression definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10 year incident case forecast, and key patient segments across the seven major markets. |
|
|
Forecast Insight: Depression - High rewards for novel and adjunctive therapies in treatment-resistant depression
Price: $15,200.00 (€11,901.13) ($18,240.00 (€14,281.35) Including VAT at 20%)
|
| Publication Date: 09-Dec-2010
Please click here for more information or to purchase this report at our partner store
Analysis of the current and future market for drugs treating depression. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products. |
|
|
Depression Market Forecast
Price: $15,200.00 (€11,901.13) ($18,240.00 (€14,281.35) Including VAT at 20%)
|
| Publication Date: 09-Dec-2010
Please click here for more information or to purchase this report at our partner store
Analysis of the current and future market for drugs treating depression. Includes sales forecasts to 2019 across the seven major markets (US, Japan, France, Germany, Italy, Spain and the UK) of key marketed brands, generics, and pipeline products. |
|
|
Stakeholder Insight: Major Depressive Disorder - Gaining traction among physicians is crucial in an SSRI-dominated market
Price: $15,200.00 (€11,901.13) ($18,240.00 (€14,281.35) Including VAT at 20%)
|
| Publication Date: 23-Dec-2010
Please click here for more information or to purchase this report at our partner store
Primary research-based analysis of the major depressive disorder market, based on a survey of 180 psychiatrists in the US, Japan, and EU. Includes epidemiology, patient segmentation, treatment trends, perception of key brands, and patient outcomes. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Be alerted by email of new featured reports
Browse upcoming events or submit your own